Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Citi
Harvard Business School
Cantor Fitzgerald
Express Scripts
Argus Health
Boehringer Ingelheim
Merck
Cipla
Chubb

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,262,169

« Back to Dashboard

Summary for Patent: 5,262,169
Title: Tablets and granulates containing mesna as active substance
Abstract:A granulate containing mesna is made by granulating mesna in the presence of an alcohol, acetone or a mixture of one of these with water. The granulate may be converted to tablets, along with other agents. The tablets contain: 0.01-1 parts by weight of a binding agent 0.03-0.4 parts by weight of a disintegrant 0.01-0.2 parts by weight of a lubricant and 0.1-1 parts by weight of a filling agent as well as, in the case of an effervescent tablet, an additional 0.05-30 parts by weight of a conventional physiologically acceptable effervescent mixture.
Inventor(s): Sauerbier; Dieter (Werter, DE), Engel; Jurgen (Alzenau, DE), Milsmann; Eckhard (Bielefeld, DE)
Assignee: Asta Medica Aktiengesellschaft (DE)
Application Number:07/730,178
Patent Claim Types:
see list of patent claims
Dosage form; Composition; Process; Formulation;

Drugs Protected by US Patent 5,262,169

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,262,169

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany4022525Jul 16, 1990

International Patents Family Members for US Patent 5,262,169

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Ireland 65373 ➤ Sign Up
Ireland 912463 ➤ Sign Up
Hungary 206630 ➤ Sign Up
Germany 59101431 ➤ Sign Up
Denmark 0468245 ➤ Sign Up
Egypt 20019 ➤ Sign Up
European Patent Office 0468245 ➤ Sign Up
Spain 2063412 ➤ Sign Up
Finland 913409 ➤ Sign Up
Finland 97949 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Argus Health
Boehringer Ingelheim
Julphar
Baxter
Dow
Accenture
Cipla
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot